Release date: 2009-04-08 Recently, a groundbreaking development in cardiac care has been announced by American researchers: a new implantable cardiac defibrillator has shown remarkable success in preventing sudden cardiac death among stroke patients. Sudden cardiac death is the leading cause of death in the United States, surpassing both lung cancer and breast cancer, and even exceeding the total number of deaths caused by AIDS each year. This makes it one of the most critical health concerns facing the nation. Studies conducted over recent years have demonstrated that patients who received this device had their mortality rate cut in half. The device functions similarly to a pacemaker, implanted in the chest to monitor and regulate heart rhythm. It works by detecting abnormal electrical activity in the heart, particularly after a heart attack, which often leads to damage in the left ventricle. When a life-threatening arrhythmia occurs, the defibrillator delivers an electric pulse to restore normal heart function. Despite its promising results, experts caution that only a small percentage of patients—less than 20%—currently benefit from this treatment. Therefore, individuals with a ventricular ejection fraction below 40% are advised to consult their doctors to determine if this preventive measure is appropriate for them. As medical technology continues to evolve, such innovations offer hope for improved outcomes and better quality of life for at-risk patients. Shanghai Medical Device Industry Association Trauma Care,Diabetic Foot Anatomy Model,Opisthenar Intravenous Injection Model,Surgical Suturing And Bandaging Model Yinchuan Erxin Technology Co., LTD , https://www.exmedmodel.com